中药对女性性早熟性特征影响的Meta分析
结果显示中药可显著缩小乳房核直径、子宫体积、卵巢体积及卵泡体积;中药联合GnRHa较单用GnRHa更能减少性特征发育,中药与GnRHa单用之间无显著差异。
要点
- 中药可显著缩小性早熟女童乳房核直径、子宫与卵巢体积及卵泡体积。
- 中药联合GnRHa较单用GnRHa更能减少性特征发育。
- 中药单用与GnRHa单用在治疗性特征方面无显著差异。
核心结论
- 中药可能有效调节女性性早熟的原发性特征。
- 中药可作为GnRHa的辅助治疗,也可能作为性早熟患者的补充治疗选择。
研究设计与样本
- 系统检索Medline、Web of Science、Scopus、中国知网、中国生物医学文献数据库及万方数据库中评估中药治疗女性性早熟的临床研究。
主要发现
- 中药显著减小乳房核直径(SMD = -1.48,95% CI [-2.04, -0.92])。
- 中药显著缩小子宫体积(SMD = -0.75,95% CI [-1.24, -0.27])。
- 中药显著缩小卵巢体积(SMD = -0.63,95% CI [-0.97, -0.30])。
- 中药显著缩小卵泡体积(SMD = -0.87,95% CI [-1.49, -0.26])。
- 亚组分析显示中药联合GnRHa较单用GnRHa显著减少性特征发育;中药与GnRHa单用之间无显著差异。
关键数值与推荐
- 主要结局包括原发与继发性特征,如子宫体积、卵巢体积及乳房核直径。
- 采用随机效应模型合并SMD及95%置信区间;并进行了敏感性分析以探讨异质性来源。
临床怎么用
- 对于女性性早熟患者,可考虑在GnRHa治疗基础上联用中药以增强对性特征发育的控制。
- 中药也可作为不适合或不愿使用GnRHa患者的补充治疗选择。
局限性
- 原文未报告纳入研究的具体类型、偏倚风险及异质性大小等细节。
- 敏感性分析虽已进行,但原文未报告异质性来源的具体结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Precocious puberty (PP) in girls is a growing concern globally, characterized by the early onset of sexual characteristics. Chinese Herbal Medicine (CHM) has been proposed as a therapeutic intervention. This meta-analysis evaluates the effects of CHM on primary and secondary sexual characteristics in females with precocious puberty. METHODS: A comprehensive literature search was conducted in Medline, Web of Science, Scopus, China National Knowledge Infrastructure Chinese Biomedical Literature Database (CBM), and Wan-fang database for clinical studies evaluating CHM in girls with precocious puberty. Key outcomes analyzed were primary and secondary sexual traits, including the uterine and ovarian volume and breast nucleus diameter. Data was pooled using a random-effects model and expressed as Standardized Mean Differences (SMD) with 95% confidence intervals. RESULTS: Twenty-five studies involving 2096 patients were included. CHM significantly decreased breast nucleus diameter (SMD = -1.48, 95% CI [-2.04, -0.92]), reduced uterine volume (SMD = -0.75, 95% CI [-1.24, -0.27]), ovarian volume (SMD = -0.63, 95% CI [-0.97, -0.30]), and follicular volume (SMD = -0.87, 95% CI [-1.49, -0.26]). Subgroup analysis showed the integration of CHM and GnRHa resulted in a notable decrease in the development of sexual traits when compared to GnRHa alone. There was no significant difference between CHM and GnRHa in treating sexual traits. Sensitivity analysis was conducted to address the source of heterogeneity. CONCLUSION: CHM appears to effectively modulate primary sexual characteristics in females with precocious puberty. The findings of this study suggest that CHM is a good choice for adjuvant therapy along with GnRHa and also may serve as a complementary treatment for patients with PP.
引用
- Wang M, Zhao R, Wang J, et al. Effect of Chinese herbal medicine on sexual characteristics of females with precocious puberty: a meta-analysis. Front Pharmacol. 2025. PMID: 41293251. doi:10.3389/fphar.2025.1703077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。